MedTrace Logo

Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction

NCT01580046 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2013-10-16

No results posted yet for this study

Summary

The purpose of this study is to compare renal toxicity of Iodixanol and Iopromide in patients with renal dysfunction.

Conditions

  • Kidney Failure, Chronic

Interventions

DRUG

iodixanol

1. coronary angiography, 32gI/100ml, 40～60 ml once injection 2. left ventricular, aortic root and selective coronary angiography, 32gI/100ml, 30～60 ml once injection

DRUG

iopromide

coronary angiography, 370mgI/ml(0.769gIopromide/ml),5～8 ml once injection

Sponsors & Collaborators

  • Yong Huo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01580046 on ClinicalTrials.gov